BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Sandro S, Benuzzi L, Lauterio A, Botta F, De Carlis R, Najjar M, Centonze L, Danieli M, Pezzoli I, Rampoldi A, Bagnardi V, De Carlis L. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection. European Journal of Surgical Oncology 2019;45:1691-9. [DOI: 10.1016/j.ejso.2019.04.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Della Corte A, Sallemi C, Ratti F, Monfardini L, Gusmini S, Cipriani F, Pennella R, Santangelo D, Burgio V, Casadei-gardini A, Aldrighetti L, De Cobelli F. Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. [DOI: 10.1007/s00270-022-03288-8] [Reference Citation Analysis]
2 Zhang S, Zhang N, Zhu W, Liu T, Lv J, Jiang W, Zhang Y, Song T, Zhang L, Xie Y, Zhou Y, Lu W. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma. Front Oncol 2022;12:946531. [DOI: 10.3389/fonc.2022.946531] [Reference Citation Analysis]
3 Bárcena-Varela M. Revealing anti-PD-1 resistance mechanisms in HCC: A path towards novel combination immunotherapies. J Hepatol 2022;77:9-11. [PMID: 35513202 DOI: 10.1016/j.jhep.2022.04.020] [Reference Citation Analysis]
4 Liu YW, Yen YH, Li WF, Wang CC, Lu SN, Kee KM, Yong CC, Cheng YF, Wang JH, Hu TH, Hung CH, Chen CH. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia. Surg Oncol 2022;42:101769. [PMID: 35468499 DOI: 10.1016/j.suronc.2022.101769] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Pocino K, Napodano C, Marino M, Di Santo R, Miele L, De Matthaeis N, Gulli F, Saporito R, Rapaccini GL, Ciasca G, Basile U. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma. Cancers (Basel) 2021;14:11. [PMID: 35008171 DOI: 10.3390/cancers14010011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang S, Lin H, Song J. Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis. Cancer Cell Int 2021;21:681. [PMID: 34923980 DOI: 10.1186/s12935-021-02365-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Radjenović B, Sabo M, Šoltes L, Prnova M, Čičak P, Radmilović-Radjenović M. On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5784. [PMID: 34830937 DOI: 10.3390/cancers13225784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ronca V, Barabino M, Santambrogio R, Opocher E, Hodson J, Bertolini E, Birocchi S, Piccolo G, Battezzati P, Cattaneo M, Podda GM. Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer. Hepatol Commun 2021. [PMID: 34716696 DOI: 10.1002/hep4.1806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Birgin E, Kaslow SR, Hetjens S, Correa-Gallego C, Rahbari NN. Minimally Invasive versus Open Liver Resection for Stage I/II Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4800. [PMID: 34638285 DOI: 10.3390/cancers13194800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yeh ML, Liang PC, Tsai PC, Wang SC, Leong J, Ogawa E, Jun DW, Tseng CH, Landis C, Tanaka Y, Huang CF, Hayashi J, Hsu YC, Huang JF, Dai CY, Chuang WL, Nguyen MH, Yu ML. Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. Cancers (Basel) 2021;13:3455. [PMID: 34298669 DOI: 10.3390/cancers13143455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wei F, Huang Q, Zhou Y, Luo L, Zeng Y. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study. World J Surg Oncol 2021;19:175. [PMID: 34127007 DOI: 10.1186/s12957-021-02277-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Barcena-Varela M, Lujambio A. The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers (Basel) 2021;13:2621. [PMID: 34073538 DOI: 10.3390/cancers13112621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ. Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systemic Review and Meta-analysis. Ann Surg. 2020;. [PMID: 33074898 DOI: 10.1097/sla.0000000000004350] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 29.0] [Reference Citation Analysis]
14 Mukherjee D, Bhatt S. Advanced drug delivery systems in hepatocellular carcinoma. Advanced Drug Delivery Systems in the Management of Cancer 2021. [DOI: 10.1016/b978-0-323-85503-7.00023-7] [Reference Citation Analysis]
15 Magistri P, Catellani B, Frassoni S, Guidetti C, Olivieri T, Assirati G, Caporali C, Pecchi A, Serra V, Ballarin R, Guerrini GP, Bagnardi V, Di Sandro S, Di Benedetto F. Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results. Cancers (Basel) 2020;12:E3578. [PMID: 33266096 DOI: 10.3390/cancers12123578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Della Corte A, Ratti F, Monfardini L, Marra P, Gusmini S, Salvioni M, Venturini M, Cipriani F, Aldrighetti L, De Cobelli F. Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma. International Journal of Hyperthermia 2020;37:542-8. [DOI: 10.1080/02656736.2020.1769869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lyu T, Wang J, Cao S, Song L, Tong X, Zou Y. Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure. J Int Med Res 2019;47:3699-708. [PMID: 31248301 DOI: 10.1177/0300060519858010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]